Organon (OGN) Misses Q4 EPS by 11c

Organon (NYSE: OGN) reported Q4 EPS of $0.81, $0.11 worse than the analyst estimate of $0.92. Revenue for the quarter came in at $1.48 billion versus the consensus estimate of $1.49 billion.

For earnings history and earnings-related data on Organon (OGN) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Organon Completes Agreement to License MIUDELLA®, Sebela Pharmaceuticals’ Hormone-Free Intrauterine Device
• CVG to join Russell 2000 and Russell 3000 indexes June 26